Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells

[1]  P. Chilton,et al.  Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF , 2014, Science Signaling.

[2]  Toshiyuki Shimizu,et al.  The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane. , 2014, International immunology.

[3]  Suzanne N. Lissenberg-Thunnissen,et al.  TLR4-mediated pro-inflammatory dendritic cell differentiation in humans requires the combined action of MyD88 and TRIF , 2014, Innate immunity.

[4]  J. Weiss,et al.  Tetraacylated Lipid A and Paclitaxel-Selective Activation of TLR4/MD-2 Conferred through Hydrophobic Interactions , 2014, The Journal of Immunology.

[5]  Jae Young Kim,et al.  Anti-CD14 antibody reduces LPS responsiveness via TLR4 internalization in human monocytes. , 2014, Molecular immunology.

[6]  E. Pearlman,et al.  CD14 Mediates Toll-like Receptor 4 (TLR4) Endocytosis and Spleen Tyrosine Kinase (Syk) and Interferon Regulatory Transcription Factor 3 (IRF3) Activation in Epithelial Cells and Impairs Neutrophil Infiltration and Pseudomonas aeruginosa Killing in Vivo* , 2013, The Journal of Biological Chemistry.

[7]  T. Mitchell,et al.  Inefficient TLR4/MD-2 Heterotetramerization by Monophosphoryl Lipid A , 2013, PloS one.

[8]  Masahiro Yamamoto,et al.  Pathogen Recognition Receptors: Ligands and Signaling Pathways by Toll-Like Receptors , 2013, International reviews of immunology.

[9]  Y. Kumazawa,et al.  Liposomal Lipopolysaccharide Initiates TRIF-Dependent Signaling Pathway Independent of CD14 , 2013, PloS one.

[10]  Satish K. Nair,et al.  The Crystal Structure of Human Soluble CD14 Reveals a Bent Solenoid with a Hydrophobic Amino-Terminal Pocket , 2013, The Journal of Immunology.

[11]  R. Fernandez,et al.  Recognition of lipid A variants by the TLR4-MD-2 receptor complex , 2012, Front. Cell. Inf. Microbio..

[12]  M. Gangloff.  Different dimerisation mode for TLR4 upon endosomal acidification? , 2012, Trends in biochemical sciences.

[13]  F. Granucci,et al.  CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4 , 2011, Cell.

[14]  R. Schumann.  Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. , 2011, Biochemical Society transactions.

[15]  P. Lepper,et al.  Location, Location, Location: Is Membrane Partitioning Everything When It Comes to Innate Immune Activation? , 2011, Mediators of inflammation.

[16]  N. Garçon,et al.  Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile , 2011, Expert opinion on biological therapy.

[17]  A. Vella,et al.  Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide. , 2010, Trends in immunology.

[18]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[19]  H. Tsukamoto,et al.  Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. , 2010, International immunology.

[20]  J. Zwaginga,et al.  Monophosphoryl lipid A plus IFNγ maturation of dendritic cells induces antigen-specific CD8+ cytotoxic T cells with high cytolytic potential , 2010, Cancer Immunology, Immunotherapy.

[21]  T. Schwarz.  Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix® , 2009, Advances in therapy.

[22]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[23]  T. Mitchell,et al.  Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant , 2008, Cellular and Molecular Life Sciences.

[24]  P. Kubes,et al.  Varying Importance of Soluble and Membrane CD14 in Endothelial Detection of Lipopolysaccharide1 , 2008, The Journal of Immunology.

[25]  K. Miyake,et al.  Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. , 2008, Biochemical and biophysical research communications.

[26]  S. Akira,et al.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.

[27]  A. ten Brinke,et al.  The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization. , 2007, Vaccine.

[28]  R. Jerala.  Structural biology of the LPS recognition. , 2007, International journal of medical microbiology : IJMM.

[29]  Y. Satow,et al.  Crystal Structures of Human MD-2 and Its Complex with Antiendotoxic Lipid IVa , 2007, Science.

[30]  Thomas C. Mitchell,et al.  The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 , 2007, Science.

[31]  M. Kundi.  New hepatitis B vaccine formulated with an improved adjuvant system , 2007, Expert review of vaccines.

[32]  R. Medzhitov,et al.  Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling , 2006, Cell.

[33]  山本 雅裕.  Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway , 2006 .

[34]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[35]  J. Silver,et al.  Influence of CD14 on Ligand Interactions between Lipopolysaccharide and Its Receptor Complex1 , 2005, The Journal of Immunology.

[36]  Zhengfan Jiang,et al.  CD14 is required for MyD88-independent LPS signaling , 2005, Nature Immunology.

[37]  C. Bingle,et al.  Meet the relatives: a family of BPI- and LBP-related proteins. , 2004, Trends in immunology.

[38]  Richard A Flavell,et al.  Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways , 2003, Nature Immunology.

[39]  B. Beutler,et al.  Lps2: a new locus required for responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic screening , 2003 .

[40]  S. Michalek,et al.  Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A , 2003, Infection and Immunity.

[41]  D. Persing,et al.  Enhancement of antigen-specific immunity via the TLR4 ligands MPL™ adjuvant and Ribi.529 , 2003, Expert review of vaccines.

[42]  P. Tobias,et al.  MD-2 binds to bacterial lipopolysaccharide , 2000, The Journal of biological chemistry.

[43]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[44]  D. Eisenberg,et al.  The three-dimensional structure of human bactericidal/permeability-increasing protein: implications for understanding protein-lipopolysaccharide interactions. , 1999, Biochemical pharmacology.

[45]  D Eisenberg,et al.  The BPI/LBP family of proteins: A structural analysis of conserved regions , 1998, Protein science : a publication of the Protein Society.

[46]  T. Espevik,et al.  Influence of CD 14, LBP and BPI in the Monocyte Response to LPS of Different Polysaccharide Chain Length , 1995, Scandinavian journal of immunology.

[47]  S. Wright,et al.  CD14 and innate recognition of bacteria. , 1995, Journal of immunology.

[48]  J. Gegner,et al.  Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14 (*) , 1995, The Journal of Biological Chemistry.

[49]  R. Munford,et al.  Enzymatically Deacylated Lipopolysaccharide (LPS) Can Antagonize LPS at Multiple Sites in the LPS Recognition Pathway (*) , 1995, The Journal of Biological Chemistry.

[50]  R. Ulevitch,et al.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  K. Kato,et al.  Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. , 1993, Journal of immunology.

[52]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[53]  De Vos,et al.  UvA-DARE ( Digital Academic Repository ) Role of CD 14 in a Mouse Model of Acute Lung Inflammation Induced by Different Lipopolysaccharide , 2010 .

[54]  K. Miyake.  Roles for accessory molecules in microbial recognition by Toll-like receptors. , 2006, Journal of endotoxin research.

[55]  R. Ulevitch,et al.  Recognition of bacterial endotoxins by receptor-dependent mechanisms. , 1993, Advances in immunology.